A Small Dose of Intraarticular Triamcinolone Plus Mepivacaine Provides a Rapid and Sustained Relief for Gout Flares.

Reumatol Clin (Engl Ed)

Sección de Reumatología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain; Catedrático emérito de Medicina (Reumatología), Universidad Miguel Hernández, Alicante, Spain. Electronic address:

Published: June 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reuma.2020.05.003DOI Listing

Publication Analysis

Top Keywords

small dose
4
dose intraarticular
4
intraarticular triamcinolone
4
triamcinolone mepivacaine
4
mepivacaine rapid
4
rapid sustained
4
sustained relief
4
relief gout
4
gout flares
4
small
1

Similar Publications

Background: Acute exacerbation (AEx) of interstitial pneumonia is the most common lethal adverse event related to the pharmacological treatment of patients with lung cancer complicated with interstitial pneumonia. Although small cell lung cancer (SCLC) is linked to poor prognosis, it exhibits good response to chemotherapy. Few previous research studies have investigated the safety and efficacy of treatment for advanced SCLC complicated with idiopathic interstitial pneumonia (IIP).

View Article and Find Full Text PDF

Prevention of sufentanil-induced cough during induction of general anesthesia by low-dose esketamine.

BMC Anesthesiol

January 2025

Department of Anesthesiology, Air Force Medical Center, No.30 Fucheng Road, Haidian District, Beijing, 100142, China.

Background: Sufentanil is commonly used to induce general anaesthesia due to its rapid onset of action, strong analgesic effect, long-lasting effect, and stable haemodynamics; however, it often induces cough, increasing the risk of anaesthesia. This study aimed to investigate the preventive effect of low-dose esketamine on sufentanil-induced cough.

Methods: This randomised, double-blind, placebo-controlled clinical study was conducted at the Air Force Medical Center between September 2023 and May 2024.

View Article and Find Full Text PDF

Background: This article is dedicated to David Farrington who was a giant in criminology and, in particular, a pioneer in studying developmental pathways of delinquent and antisocial behaviour. Numerous studies followed his work. Systematic reviews of his and others' research described between two and seven (mainly 3-5) trajectories.

View Article and Find Full Text PDF

The Space Radiobiological Exposure Facility (SREF) is a general experimental facility at the China Space Station for scientific research in the fields of space radiation protection, space radiation biology, biotechnology, and the origin of life. The facility provides an environment with controllable temperatures for experiments with organic molecules and model organisms such as small animals, plant seeds, and microorganisms. The cultivation of small animals can be achieved in the facility with the use of microfluidic chips and images and videos of such experiments can be captured by microscopy.

View Article and Find Full Text PDF

Impact of Sotorasib, a KRAS G12C Inhibitor, on the Pharmacokinetics and Therapeutic Window of Digoxin, a P-Glycoprotein Substrate.

Clin Pharmacol Drug Dev

January 2025

Clinical Pharmacology Modeling and Simulation, Amgen Inc., Thousand Oaks, CA, USA.

Sotorasib is a small-molecule Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C inhibitor indicated for the treatment of KRAS G12C-driven cancers. KRAS G12C is a common mutation in solid tumors, including non-small cell lung cancer. In vitro studies suggested that sotorasib is a weak inhibitor of P-glycoprotein transporter.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!